ProMIS Neurosciences Inc reports results for the quarter - Earnings Summary

ProMIS Neurosciences

14/11/2024 20:56

* ProMIS Neurosciences Inc  PMN.OQ  reported quarterly
adjusted
earnings of 42 cents​​ per share for the quarter , higher than
the same quarter last year, when the company reported EPS of -19
cents.  The lone analyst forecast for the quarter was for a loss
of 7 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * ProMIS Neurosciences Inc's reported EPS for the quarter
was 31
cents​.
    * The company reported quarterly net income of $9.28
million.
    * ProMIS Neurosciences Inc shares had fallen by 21.6% this
quarter and lost 14.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "buy."

Wall Street's median 12-month price target for ProMIS
Neurosciences Inc is $8.75 
This summary was machine generated from LSEG data November 14 at
08:55 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.07          0.42           Beat
 Jun. 30 2024      -0.14          -0.13          Beat
 Mar. 31 2024      -0.20          -0.19          Beat
 Dec. 31 2023      -0.17          -0.29          Missed